Discontinued — last reported Q2 '20
West Pharmaceutical Services Lease Liability Payments - Due Year Four decreased by 18.1% to $10.40M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 15.4%, from $12.30M to $10.40M. Over 3 years (FY 2020 to FY 2023), Lease Liability Payments - Due Year Four shows relatively stable performance with a 3.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Consistent growth in these payments may indicate expansion of physical footprint or equipment fleet.
The projected cash payments for operating and finance leases scheduled for the fourth year following the balance sheet d...
Standard disclosure for lease maturity profiles.
lease_liability_payments_due_year_4| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.90M | $6.80M | $8.20M | $8.40M | $8.70M | $11.60M | $13.40M | $9.30M | $9.40M | $9.80M | $9.50M | $10.10M | $13.80M | $14.10M | $12.30M | $12.80M | $12.70M | $10.40M |
| QoQ Change | — | -1.4% | +20.6% | +2.4% | +3.6% | +33.3% | +15.5% | -30.6% | +1.1% | +4.3% | -3.1% | +6.3% | +36.6% | +2.2% | -12.8% | +4.1% | -0.8% | -18.1% |
| YoY Change | — | — | — | — | +26.1% | +70.6% | +63.4% | +10.7% | +8.0% | -15.5% | -29.1% | +8.6% | +46.8% | +43.9% | +21.8% | -7.2% | -9.9% | -15.4% |